The requirement for every Food Business Operator to obtain an FSSAI license or registration is explicitly stated in Section 31(1) of the Food Safety and Standards Act, 2006, which states that "No person shall commence or carry on any food business except under a License". This applies to all businesses, regardless of size, from large manufacturers and importers to petty retailer. Food Safety and Standards Act, 2006 for businesses involved in manufacturing, importing, marketing, distributing, relabelling, storing, or selling food products in India, including nutraceuticals, health supplements, and dietary products.
FSSAI compliance supports lawful market access, labeling accuracy, and smoother distribution for nutraceutical and health supplement products.
We help nutraceutical and health supplement businesses address classification, documentation, labeling, and FoSCoS filing issues with a structured compliance approach.
End-to-end support for FSSAI registration, FoSCoS filing, classification, documentation, and labeling readiness.
Reliable support for nutraceutical and food regulatory compliance, from documentation to submission and follow-up.
FAQ
A Risk Management Plan (RMP) is a regulatory document describing identified and potential safety risks associated with a product along with proposed risk minimisation activities.
PSUR (Periodic Safety Update Report) and PBRER (Periodic Benefit-Risk Evaluation Report) are periodic safety reports prepared for marketed products to evaluate ongoing product safety and benefit-risk balance.
No. Our support is focused on pharmacovigilance documentation and regulatory reporting support activities.
Yes. We support preparation and review of pharmacovigilance SOPs and process documentation.
Yes. Existing PV documentation can be reviewed for consistency and regulatory alignment.
Yes. We support preparation and compilation of PSUR / PBRER documentation.
Yes. Support is available for updating safety-related documentation during product lifecycle activities.
Support can be provided for pharmaceutical products requiring post-marketing safety documentation activities.
Yes. We support review and gap assessment of available PV documentation and procedures.
Support can be provided for preparation of pharmacovigilance documentation aligned with applicable market requirements.
Fill in the form and our team will get back to you shortly.
Reach our regulatory experts directly.